Zobrazeno 1 - 4
of 4
pro vyhledávání: '"V. Sygyrta"'
Autor:
G. Gridneva, Y. Muraviev, Anna V. Kudryavtseva, N. Baymeeva, E. Samarkina, Svetlana Glukhova, V. Sygyrta, E. Aronova
Publikováno v:
Annals of the Rheumatic Diseases. 80:1158.1-1158
Background:7-hydroxy Methotrexate (7-hydroxy-MTX) is a phase I metabolite of MTX, which is converted by hepatic aldehyde oxidases. It is known that 7-hydroxy MTX can reduce the effectiveness of methotrexate, which is associated with increased excreti
Publikováno v:
Annals of the Rheumatic Diseases. 80:1138.2-1139
Background:Refractory rheumatoid arthritis (RRA) is a subtype of rheumatoid arthritis (RA), in which the sequential administration of optimal methotrexate doses in combination with glucocorticoids, and at least - two biologic disease-modifying antirh
Autor:
Anna V. Kudryavtseva, Alexander Lila, G. Gridneva, V. Sygyrta, Y. Muraviev, E. Samarkina, N. Baymeeva, E. Aronova
Publikováno v:
Annals of the Rheumatic Diseases. 80:465.2-465
Background:Studying the dynamics of the methotrexate metabolites concentration in cells will help to predict the therapeutic effect and assess patient compliance. We suggest that studying the dynamics of changes in the concentration of methotrexate m
Publikováno v:
Annals of the Rheumatic Diseases. 79:1461.1-1461
Background:Refractory rheumatoid arthritis (RRA) is a subtype of rheumatoid arthritis (RA), in which the sequential administration of optimal methotrexate (MT) doses in combination with glucocorticoids (GCs), and at least - two biologic disease-modif